ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
3,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Deafness,Hearing losses,Hearing disorders,Ear,N
4,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
4,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
6,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
7,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
8,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
10,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
11,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
12,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
12,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
13,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
13,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
14,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
14,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
14,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
15,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
16,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
17,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
17,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
18,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
18,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
18,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
19,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
20,1,Necrotising soft tissue infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,Y
21,1,Bacterial disease carrier,Infectious disorders carrier,Ancillary infectious topics,Infec,N
21,2,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
21,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
21,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
21,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
21,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
21,7,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
21,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
22,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
22,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
22,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
22,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
22,5,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
23,1,Breast cancer recurrent,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
24,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
24,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
25,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
26,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
26,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
26,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
26,4,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
27,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
27,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
28,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
28,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
28,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
28,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
29,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
29,2,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
29,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
29,4,Suprapubic pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
30,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
31,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
32,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
32,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
32,3,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
32,4,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
32,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
32,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
32,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
32,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
32,9,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
32,10,Viral diarrhoea,Viral infections NEC,Viral infectious disorders,Infec,N
32,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
33,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
33,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
33,3,Post inflammatory pigmentation change,Pigmentation changes NEC,Pigmentation disorders,Skin,N
33,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
33,5,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
33,6,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
33,7,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
34,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
34,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
35,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
36,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
36,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
36,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
36,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
37,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
37,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
38,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
38,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
38,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
38,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
39,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
39,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
39,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
39,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
40,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
40,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
41,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
41,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
42,1,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
42,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
43,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
44,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
45,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
46,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
47,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
47,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
47,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
47,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
47,5,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
47,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
47,7,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
48,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
48,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
48,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
48,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
48,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
48,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
49,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
49,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
50,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
50,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
50,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
51,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
51,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
51,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
51,4,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
51,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
51,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
51,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
51,8,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
51,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
51,10,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
51,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
52,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
53,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
53,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
54,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,2,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
55,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
56,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
56,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
56,3,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
56,4,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
56,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
56,6,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
56,7,Procedural vomiting,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
56,8,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
56,9,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
57,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
57,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
57,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
58,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
59,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
60,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
61,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
62,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
63,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
63,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
63,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
63,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
63,5,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
63,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
64,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
64,2,Headache,Headaches NEC,Headaches,Nerv,N
64,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
64,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
64,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
64,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
65,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
66,1,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
67,1,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
68,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
69,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
69,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
70,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
70,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
71,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
71,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
71,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
71,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
71,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
72,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
73,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
74,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
75,1,Alanine aminotransferase,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
75,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
75,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
76,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
77,1,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
78,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
78,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
78,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
78,4,Hypertensive urgency,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
78,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
78,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
78,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
79,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
79,2,Allergic respiratory symptom,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
79,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
79,4,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
79,5,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
79,6,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
79,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
79,8,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
79,9,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
80,1,Eye contusion,Eye injuries NEC,Injuries NEC,Inj&P,N
80,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
80,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
80,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
81,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
81,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
81,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
81,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
82,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
82,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
83,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
84,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
85,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
85,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
85,3,Perforation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
85,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
86,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
87,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
87,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
87,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
88,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
89,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
90,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
90,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
90,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
90,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
91,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
91,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
91,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
92,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
92,2,Pharyngeal paraesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
93,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
93,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
93,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
94,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
95,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
95,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
95,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
96,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
96,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
97,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
98,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
99,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
100,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
100,2,Headache,Headaches NEC,Headaches,Nerv,N
101,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
102,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
102,2,Wound healing normal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
103,1,Headache,Headaches NEC,Headaches,Nerv,N
103,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
103,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
103,4,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
103,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
104,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
105,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
105,2,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
105,3,Arterial haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
105,4,Atelectasis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
105,5,Bladder pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
105,6,Pelvic haematoma,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
105,7,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
105,8,Ureteric dilatation,Ureteric disorders NEC,Ureteric disorders,Renal,N
105,9,Ureteric obstruction,Ureteric disorders NEC,Ureteric disorders,Renal,N
106,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
106,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
107,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
107,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
108,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
108,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
109,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
110,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
110,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
110,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
110,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
110,5,Patella fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
111,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
111,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
112,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
112,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
112,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
113,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
114,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
114,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
114,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
115,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
116,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
116,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
116,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
116,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
117,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
118,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
119,1,Headache,Headaches NEC,Headaches,Nerv,N
119,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
119,3,Juvenile idiopathic arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
119,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
120,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
120,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
121,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
121,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
122,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
122,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
122,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
122,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
122,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
122,6,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
123,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
124,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
125,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
126,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
127,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
128,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
128,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
129,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
130,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
131,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
131,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
131,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
131,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
132,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
132,2,Bloody discharge,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
132,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
132,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
132,5,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
132,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
132,7,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
132,8,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
133,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
133,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
133,3,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
134,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
134,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
135,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
136,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
137,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
137,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
137,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
138,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
138,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
139,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
140,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
140,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
141,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
141,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
141,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
141,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
142,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
143,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
143,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
143,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
144,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
145,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
145,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
145,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
146,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
146,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
147,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
147,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
148,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
148,2,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
148,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
149,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
149,2,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
150,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
150,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
151,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
152,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
152,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
152,3,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
152,4,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
152,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
153,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
153,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
154,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
154,2,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
155,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
156,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
157,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
157,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
158,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
159,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
159,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
159,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
159,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
160,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
160,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
160,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
161,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
161,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
161,3,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
162,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
162,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
162,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
162,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
162,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
162,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
162,7,Headache,Headaches NEC,Headaches,Nerv,N
162,8,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
162,9,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
163,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
164,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
164,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
164,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
164,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
165,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
166,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
166,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
167,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
168,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
168,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
168,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
169,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
169,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
170,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
171,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
172,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
172,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
172,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
173,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
174,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
174,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
175,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
175,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
176,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
177,1,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
178,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
178,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
179,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
179,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
180,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
182,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
182,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
182,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
182,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
183,1,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
183,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
183,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
184,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
185,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
185,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
185,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
185,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
186,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
186,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
187,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
187,2,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
187,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
188,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
188,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
188,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
189,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
190,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
190,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
190,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
190,4,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
190,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
191,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
191,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
191,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
191,4,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
192,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
192,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
192,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
192,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
193,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
193,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
193,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
194,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
194,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
194,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
194,4,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
195,1,Headache,Headaches NEC,Headaches,Nerv,N
196,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
197,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
197,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
198,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
199,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
199,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
199,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
199,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
200,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
200,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
201,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
201,2,Nasal obstruction,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
201,3,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
201,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
202,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
202,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
202,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
202,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
203,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
203,2,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
204,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
205,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
206,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
206,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
206,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
206,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
207,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
208,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
209,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
209,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
209,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
210,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
211,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
211,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
212,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
212,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
212,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
212,4,Headache,Headaches NEC,Headaches,Nerv,N
212,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
212,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
212,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
212,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
212,9,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
212,10,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
212,11,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
213,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
214,1,Headache,Headaches NEC,Headaches,Nerv,N
214,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
214,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
215,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
215,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
215,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
216,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
216,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
217,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
218,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
218,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
218,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
218,4,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
218,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
219,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
220,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
221,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
222,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
222,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
222,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
223,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
223,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
223,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
224,1,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
224,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
225,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
226,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
226,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
227,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
228,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
228,2,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
228,3,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
228,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
229,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
229,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
229,3,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
230,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
231,1,Leg amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
231,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
231,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
232,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
232,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
232,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
233,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
234,1,Orchitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
234,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
235,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
236,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
236,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
236,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
237,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
238,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
239,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
240,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
241,1,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
242,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
243,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
243,2,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
244,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
245,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
246,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
247,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
247,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
247,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
248,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
248,2,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
249,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
250,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
250,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
250,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
250,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
250,5,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
251,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
251,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
252,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
253,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
253,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
254,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
254,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
255,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
255,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
256,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
257,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
257,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
257,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
258,1,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
259,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
259,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
259,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
260,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
260,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
261,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
261,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
262,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
263,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
263,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
263,3,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
263,4,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
264,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
264,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
264,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
264,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
265,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
266,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
266,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
267,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
268,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
268,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
269,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
269,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
270,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
271,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
271,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
271,3,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
271,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
271,5,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
271,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
271,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
272,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
273,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
273,2,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
274,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
275,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
276,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
276,2,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
276,3,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
276,4,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
276,5,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
276,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
276,7,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
276,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
276,9,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
276,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
276,11,Headache,Headaches NEC,Headaches,Nerv,N
276,12,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
276,13,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
276,14,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
276,15,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
276,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
276,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
276,18,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
276,19,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
277,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
277,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
278,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
279,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
280,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
281,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
281,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
282,1,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
283,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
283,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
283,3,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
284,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
285,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
286,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
287,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
288,1,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
288,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
289,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
289,2,Madarosis,Alopecias,Skin appendage conditions,Skin,N
290,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
290,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
291,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
291,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
291,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
291,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
292,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
293,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
294,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
294,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
294,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
294,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
295,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
295,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
296,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
297,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
298,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
298,2,Headache,Headaches NEC,Headaches,Nerv,N
298,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
298,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
299,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
300,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
300,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
300,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
300,4,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
300,5,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
300,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
300,7,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
301,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
301,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
302,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
302,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
303,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
304,1,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
304,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
305,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
306,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
306,2,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
306,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
307,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
307,2,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
308,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
309,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
310,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
310,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
310,3,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
310,4,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
311,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
311,2,Headache,Headaches NEC,Headaches,Nerv,N
311,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
312,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
313,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
313,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
313,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
314,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
315,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
315,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
315,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
315,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
316,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
316,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
317,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
317,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
318,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
318,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
319,1,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
319,2,Vocal cord thickening,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
320,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
321,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
321,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
322,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
323,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
323,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
323,3,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
324,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
325,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
325,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
325,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
325,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
326,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
327,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
328,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
328,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
328,3,Headache,Headaches NEC,Headaches,Nerv,N
328,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
328,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
328,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
328,7,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
329,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
330,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
331,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
331,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
332,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
332,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
332,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
332,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
333,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
333,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
334,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
334,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
335,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
336,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
336,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
337,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
337,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
338,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
339,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
339,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
340,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
341,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
341,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
341,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
342,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
343,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
343,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
343,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
343,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
343,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
344,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
345,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
346,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
346,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
346,3,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
346,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
346,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
346,6,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
347,1,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
348,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
348,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
348,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
348,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
348,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
348,6,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
349,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
350,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
350,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
351,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
352,1,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
352,2,Limb operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
352,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
352,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
352,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
353,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
354,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
355,1,Aortic dissection,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
355,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
355,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
356,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
356,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
356,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
357,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
357,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
357,3,Headache,Headaches NEC,Headaches,Nerv,N
357,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
357,5,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
358,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
358,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
358,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
358,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
359,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
359,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
360,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
361,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
361,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
361,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
362,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
363,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
364,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
364,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
364,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
364,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
365,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
366,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
366,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
366,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
366,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
366,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
367,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
367,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
367,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
367,4,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
367,5,Headache,Headaches NEC,Headaches,Nerv,N
368,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
368,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
368,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
369,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
369,2,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
370,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
371,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
372,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
372,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
372,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
372,4,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
373,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
373,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
374,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
374,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
374,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
375,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
376,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
377,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
377,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
377,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
378,1,Migraine,Migraine headaches,Headaches,Nerv,N
379,1,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
380,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
381,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
382,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
382,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
382,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
382,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
382,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
382,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
383,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
384,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
384,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
384,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
384,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
385,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
385,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
385,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
386,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
386,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
386,3,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
387,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
388,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
388,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
389,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
389,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
390,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
390,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
391,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
391,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
391,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
392,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
392,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
393,1,Craniofacial fracture,"Skull fractures, facial bone fractures and dislocations",Bone and joint injuries,Inj&P,N
393,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
393,3,Labyrinthitis,Ear infections,Infections - pathogen unspecified,Infec,N
393,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
393,5,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
394,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
394,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
394,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
394,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
394,5,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
395,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
395,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
395,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
396,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
397,1,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
398,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
399,1,Migraine,Migraine headaches,Headaches,Nerv,N
400,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
401,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
401,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
401,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
402,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
403,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
403,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
403,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
404,1,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
404,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
405,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
406,1,Contraindication to medical treatment,Social issues NEC,Lifestyle issues,SocCi,N
406,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
407,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
407,2,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
407,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
407,4,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
407,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
407,6,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
407,7,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
408,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
408,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
409,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
409,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
409,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
409,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
409,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
409,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
410,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
410,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
411,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
411,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
412,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
413,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
413,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
414,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
414,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
414,3,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
415,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
415,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
415,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
416,1,Arthropod sting,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
416,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
417,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
417,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
418,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
419,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
420,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
420,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
420,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
421,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
421,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
421,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
422,1,Lung cancer metastatic,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
423,1,White blood cell count,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
424,1,Herpes simplex reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
424,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
424,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
424,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
425,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
425,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
425,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
426,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
426,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
427,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
428,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
428,2,Epicondylitis,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
428,3,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
428,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
428,5,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
428,6,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
428,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
429,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
430,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
431,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
431,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
431,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
432,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
432,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
433,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
434,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
435,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
436,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
437,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
438,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
439,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
439,2,Headache,Headaches NEC,Headaches,Nerv,N
439,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
439,4,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
439,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
439,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
440,1,Pharyngeal haemorrhage,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
441,1,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
441,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
441,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
442,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
442,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
442,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
442,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
443,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
444,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
445,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
446,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
447,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
447,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
448,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
448,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
449,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
449,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
450,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
450,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
450,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
450,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
450,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
450,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
451,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
451,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
452,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
452,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
453,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
454,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
455,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
455,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
455,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
455,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
455,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
455,6,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
455,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
456,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
456,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
457,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
457,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
458,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
458,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
458,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
459,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
459,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
459,3,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
459,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
460,1,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
460,2,Perinephric abscess,Urinary tract infections,Infections - pathogen unspecified,Infec,N
461,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
462,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
463,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
463,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
464,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
464,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
464,3,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
464,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
464,5,Loose tooth,Dental disorders NEC,Dental and gingival conditions,Gastr,N
464,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
464,7,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
464,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
465,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
465,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
465,3,Headache,Headaches NEC,Headaches,Nerv,N
466,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
466,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
466,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
466,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
467,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
468,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
469,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
470,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
470,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
471,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
471,2,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
472,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
472,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
473,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
474,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
475,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
475,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
476,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
477,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
477,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
477,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
477,4,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
478,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
478,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
478,3,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
479,1,Hip surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
479,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
479,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
480,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
480,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
480,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
481,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
481,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
481,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
481,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
482,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
483,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
483,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
484,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
485,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
485,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
486,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
487,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
487,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
488,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
488,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
488,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
488,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
489,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
489,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
490,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
491,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
491,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
491,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
491,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
492,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
492,2,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
492,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
493,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
493,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
493,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
493,4,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
494,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
494,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
495,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
496,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
497,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
497,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
498,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
499,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
499,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
500,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
500,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
501,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
502,1,Administration site dryness,Administration site reactions NEC,Administration site reactions,Genrl,N
502,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
502,3,Headache,Headaches NEC,Headaches,Nerv,N
503,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
503,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
503,3,Headache,Headaches NEC,Headaches,Nerv,N
503,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
504,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
505,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
506,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
506,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
506,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
507,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
507,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
508,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
508,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
509,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
510,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
510,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
510,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
511,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
512,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
512,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
512,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
513,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
513,2,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
513,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
513,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
513,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
514,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
515,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
516,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
516,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
516,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
516,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
516,5,Headache,Headaches NEC,Headaches,Nerv,N
516,6,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
516,7,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
517,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
517,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
518,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
